Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B.
Cost-effectiveness analysis of lamivudine for the treatment of chronic hepatitis B. Pharmacoeconomics. 2000 May; 17(5):409-27.
View in:
PubMed
subject areas
Antiviral Agents
Cost-Benefit Analysis
Hepatitis B, Chronic
Humans
Interferon-alpha
Lamivudine
authors with profiles
Stephanie J. Crowley